StonvexLoading…
StonvexStonvexStonvexCore line items from NEOV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $8.43M | $2.65M | $3.46M | $4.47M |
Operating Income | $-4.72M | $-2.34M | $-2.64M | $-5.76M |
Net Income | $-5.03M | $-2.30M | $-2.64M | $-5.80M |
EPS (Diluted) | $-0.15 | $-0.07 | $-0.08 | $-0.28 |
Total Assets | $6.81M | $4.66M | $6.51M | $4.13M |
Total Liabilities | $3.90M | $61.10K | $39.49K | $1.51M |
Cash & Equivalents | $794.84K | $986.43K | $2.00M | $330.38K |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 34.12M | 33.24M | 33.16M | 21.98M |